1. Cardiovascular disease and diabetes in HIV‐positive and HIV‐negative gay and bisexual men over the age of 55 years in Australia: insights from the Australian Positive & Peers Longevity Evaluation Study. Issue 2 (26th November 2018) Authors: Puhr, R; Petoumenos, K; Huang, R; Templeton, DJ; Woolley, I; Bloch, M; Russell, D; Law, MG; Cooper, DA Journal: HIV medicine Issue: Volume 20:Issue 2(2019) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetic and Pharmacodynamic Comparison of Once‐Daily Efavirenz (400 mg vs. 600 mg) in Treatment‐Naïve HIV‐Infected Patients: Results of the ENCORE1 Study. Issue 4 (14th July 2015) Authors: Dickinson, L; Amin, J; Else, L; Boffito, M; Egan, D; Owen, A; Khoo, S; Back, D; Orrell, C; Clarke, A; Losso, M; Phanuphak, P; Carey, D; Cooper, DA; Emery, S Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 4(2015:Oct.) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗